Biogen Chemicals & Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading medicine, tablets, syrups, and capsules since 2011.
2011 | Delhi (India) | Active
Biogen Chemicals & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 335.83%
- Profit Growth 195.18%
- Ebitda 184.73%
- Net Worth 39.13%
- Total Assets 8.74%
About Biogen Chemicals & Pharmaceuticals
Biogen Chemicals & Pharmaceuticals Private Limited (BCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 June 2011 and has a history of 13 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pushpa Davi and Deep Chaudhary serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2011PTC221556
- Company No.
221556
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2011
- Date of AGM
28 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Biogen Chemicals & Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpa Davi  | Director | 28-Jun-2011 | Current |
| Deep Chaudhary | Director | 28-Jun-2011 | Current |
Financial Performance of Biogen Chemicals & Pharmaceuticals.
Biogen Chemicals & Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 335.83% increase. The company also saw a substantial improvement in profitability, with a 195.18% increase in profit. The company's net worth Soared by an impressive increase of 39.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogen Chemicals & Pharmaceuticals?
In 2019, Biogen Chemicals & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biogen Chemicals & Pharmaceuticals?
Unlock and access historical data on people associated with Biogen Chemicals & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogen Chemicals & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogen Chemicals & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.